Medinet Co Company
%20.jpg)
Cancer immuno-cell therapy is an advanced medical practice.
Total Funding:
511490000
Headquarters:
Japan
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Technology:
Regenerative Medicine
Investor Type:
For Profit
Last Funding Date:
42276
Investors Number:
1
Founded Date:
1995-01-01
Industry:
Biotechnology, Health Care, Medical, Therapeutics